AstraZeneca Settles Nexium Kickback Suit; Deals Prohibiting Authorized Generic Sales Alleged
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca agreed to pay $7.9 million to resolve allegations it paid kickbacks to Medco Health Solutions for preferred formulary placement of Nexium.
You may also be interested in...
Pharma Deals With The DOJ
A look at the settlement agreements pharma companies have struck with the Department of Justice in the last three years; the size of the deals has declined dramatically since 2012.
Does Former Warner Chilcott Exec’s Arrest Portend More Prosecutions?
Carl Reichel indicted for conspiring to pay kickbacks to physicians while firm pleads guilty to health care fraud; former DOJ attorneys provide insights on case.
Kickback Suit Against Novartis Can Proceed, Judge Says
Federal judge rules against Novartis’ motion to dismiss a whistleblower suit alleging violations of the anti-kickback statute and the False Claims Act, saying the government’s evidence is specific enough to proceed.